Cocrystal Pharma (COCP) Change in Cash (2010 - 2026)

Cocrystal Pharma has reported Change in Cash for 17 years, with the latest figure at -$2.3 million in Q1 2026.

• Quarterly Change in Cash rose 20.38% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 million (up 85.01% YoY) and the FY2025 annual result came in at -$2.8 million, up 82.81% from the prior year.
• Change in Cash eased to -$2.3 million in Q1 2026 per COCP's latest filing, from -$704000.0 in the prior quarter.
• Over five years, Change in Cash peaked at $3.0 million in Q3 2025 and troughed at -$9.0 million in Q3 2022.
• A 5-year average of -$3.2 million and a median of -$3.2 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2025: Change in Cash sank 1561.19% in 2022, then jumped 157.84% in 2025.
• Over 5 years, Change in Cash stood at -$4.9 million in 2022, then jumped by 31.09% to -$3.4 million in 2023, then climbed by 6.65% to -$3.2 million in 2024, then surged by 77.72% to -$704000.0 in 2025, then plunged by 232.39% to -$2.3 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$2.3 million, -$704000.0, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.